Physician profile
Daniel Stewart
NPI 1992082838
$1,752.50
in general payments reported to CMS, 2019-2025
22 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $39.04 · 2021: $68.04 · 2022: $376 · 2023: $467 · 2024: $541 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $666.60 | 2019-2024 | |
| Pfizer INC. | $159.59 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $119.23 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $117.96 | 2022-2025 | Camzyos |
| Edwards Lifesciences Corporation | $99.51 | 2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals Lp | $94.81 | 2019-2023 | Brilinta, Farxiga |
| Amgen INC. | $88.65 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.08 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.71 | 2021-2025 | Jardiance |
| Vital Connect, INC | $43.01 | 2024-2025 | Vitalpatch Rtm |
| Irhythm Technologies, INC. | $29.25 | 2024 | Zio Monitor, Zio Xt Patch |
| Arbor Pharmaceuticals, INC. | $28.42 | 2019 | |
| Boston Scientific Corporation | $20.71 | 2023 | Watchman Access System |
| Kiniksa Pharmaceuticals International, Plc | $20.60 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $20.04 | 2024 | Uptravi, Opsumit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.38 | 2025 | Linq II |
| Siemens Medical Solutions USA, INC. | $19.00 | 2024 | Artis Icono Floor |
| Merck Sharp & Dohme LLC | $18.18 | 2022 | |
| Lantheus Medical Imaging, INC. | $17.73 | 2025 | |
| Daiichi Sankyo INC. | $16.14 | 2023 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $14.40 | 2024 | |
| Esperion Therapeutics, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.